Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
about
Emerging and investigational drugs for premature ejaculationEfficacy and Safety of the Selective α1A-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in KoreaNew clinical evidence of silodosin, an α(1A) selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms.A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasiaMR imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluation.Advances in understanding and treating premature ejaculation.Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia: a randomized controlled trial.Personalized therapeutics of α₁-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Relationship between endothelial dysfunction and nocturia with benign prostatic hyperplasia.Premature ejaculation: challenging new and the old concepts.
P2860
Q28078002-69269864-B2D7-4025-ABD2-9F94A642E1D6Q33633716-B06A57A5-12D9-4DAB-BBB5-DE0A71C68208Q34635165-2374BF49-FF76-4D49-948B-57E94B109B88Q36780186-B2AB7FB4-708D-46F7-9776-A1D21B6C2BE0Q38185148-45C1461E-B53F-4A7E-A25E-73761D67B5A2Q38616683-1DC15434-F23B-4D8D-8FC2-308B12633215Q41652645-628C3B0C-A60B-4BF4-BA09-AD8C897098A2Q42653540-2077984E-B2D4-4419-B173-104EA2D503AFQ45309524-FB30F833-211F-4EFB-88D1-4208F236495EQ47139929-5D9231A9-4472-4495-90AD-02C7F0225A11
P2860
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
@ast
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
@en
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
@nl
type
label
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
@ast
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
@en
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
@nl
prefLabel
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
@ast
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
@en
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
@nl
P2093
P2860
P921
P356
P1476
Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
@en
P2093
Junzo Kudoh
Kazuki Kawabe
Masaki Yoshida
Yukio Homma
P2860
P304
P356
10.2147/CIA.S13803
P407
P577
2011-06-22T00:00:00Z